Inception Point Ai
Mounjaro vs Ozempic — Which One Works Better?
The SURMOUNT-5 trial just settled the debate: tirzepatide delivered 47% more weight loss than semaglutide in the first major head-to-head study. Dr. Ben Synth analyzes the science behind dual-agonist therapy, dissects the real-world data, and explores what this means for patients choosing between these blockbuster medications. For more content like this, visit QuietPlease.ai
Copyright 2025 Inception Point Ai
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.